PULMONX CORPORATION (LUNG) Deferred State and Local Income Tax Expense (Benefit)

PULMONX CORPORATION Deferred State and Local Income Tax Expense (Benefit)

PULMONX CORPORATION (LUNG) reported Deferred State and Local Income Tax Expense (Benefit) of $5.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-03-10

• PULMONX CORPORATION deferred state and local income tax expense (benefit) for fiscal 2025 was $5.00K, a 37.50% decline from fiscal 2024.
• PULMONX CORPORATION deferred state and local income tax expense (benefit) for fiscal 2024 was $8.00K, a 20.00% decline from fiscal 2023.
• PULMONX CORPORATION deferred state and local income tax expense (benefit) for fiscal 2023 was $10.00K, a 28.57% decline from fiscal 2022.
• PULMONX CORPORATION deferred state and local income tax expense (benefit) for fiscal 2022 was $14.00K.